SOURCE-LINKED STUDY SUMMARY
CARDIOVASCULAR EFFECTS OF INCRETIN RECEPTOR AGONISTS: BEYOND GLYCEMIC CONTROL.
Abstract summarized · Quality not appraised
- Studied
- A review of cardiovascular research on single, dual and triple incretin-receptor agonists, including effects beyond blood-sugar control.
- Who / model
- Evidence includes isolated human heart tissue and imaging in obesity-related heart failure. The abstract gives no pooled sample size or single follow-up period.
- Studied dose & schedule
- Dose and schedule have not yet been extracted for this summary.
- Found
- The review reports stronger contraction in isolated atrial tissue and reverse heart-chamber remodeling with tirzepatide in obesity-related heart failure.
- Limits
- For triple agonists, phase 2 findings concerned surrogate measures; phase 3 cardiovascular outcome results were still awaited.
Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary
Research findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1139/cjpp-2026-0184